Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses

Abstract Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To help understand ErbB signaling quantitatively, in this work we combine traditional experiments with computational modeling, building a model that describes how stimulation of all four ErbB recep...

Full description

Saved in:
Bibliographic Details
Main Authors: Marc R Birtwistle, Mariko Hatakeyama, Noriko Yumoto, Babatunde A Ogunnaike, Jan B Hoek, Boris N Kholodenko
Format: Article
Language:English
Published: Springer Nature 2007-11-01
Series:Molecular Systems Biology
Subjects:
Online Access:https://doi.org/10.1038/msb4100188
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225762228404224
author Marc R Birtwistle
Mariko Hatakeyama
Noriko Yumoto
Babatunde A Ogunnaike
Jan B Hoek
Boris N Kholodenko
author_facet Marc R Birtwistle
Mariko Hatakeyama
Noriko Yumoto
Babatunde A Ogunnaike
Jan B Hoek
Boris N Kholodenko
author_sort Marc R Birtwistle
collection DOAJ
description Abstract Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To help understand ErbB signaling quantitatively, in this work we combine traditional experiments with computational modeling, building a model that describes how stimulation of all four ErbB receptors with epidermal growth factor (EGF) and heregulin (HRG) leads to activation of two critical downstream proteins, extracellular‐signal‐regulated kinase (ERK) and Akt. Model analysis and experimental validation show that (i) ErbB2 overexpression, which occurs in approximately 25% of all breast cancers, transforms transient EGF‐induced signaling into sustained signaling, (ii) HRG‐induced ERK activity is much more robust to the ERK cascade inhibitor U0126 than EGF‐induced ERK activity, and (iii) phosphoinositol‐3 kinase is a major regulator of post‐peak but not pre‐peak EGF‐induced ERK activity. Sensitivity analysis leads to the hypothesis that ERK activation is robust to parameter perturbation at high ligand doses, while Akt activation is not.
format Article
id doaj-art-5308beffef2345ef98a807eb6d85b538
institution Kabale University
issn 1744-4292
language English
publishDate 2007-11-01
publisher Springer Nature
record_format Article
series Molecular Systems Biology
spelling doaj-art-5308beffef2345ef98a807eb6d85b5382025-08-24T12:02:06ZengSpringer NatureMolecular Systems Biology1744-42922007-11-013111610.1038/msb4100188Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analysesMarc R Birtwistle0Mariko Hatakeyama1Noriko Yumoto2Babatunde A Ogunnaike3Jan B Hoek4Boris N Kholodenko5Department of Chemical Engineering, University of DelawareComputational and Experimental Systems Biology Group, RIKEN Genomic Sciences CenterComputational and Experimental Systems Biology Group, RIKEN Genomic Sciences CenterDepartment of Chemical Engineering, University of DelawareDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson UniversityDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson UniversityAbstract Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To help understand ErbB signaling quantitatively, in this work we combine traditional experiments with computational modeling, building a model that describes how stimulation of all four ErbB receptors with epidermal growth factor (EGF) and heregulin (HRG) leads to activation of two critical downstream proteins, extracellular‐signal‐regulated kinase (ERK) and Akt. Model analysis and experimental validation show that (i) ErbB2 overexpression, which occurs in approximately 25% of all breast cancers, transforms transient EGF‐induced signaling into sustained signaling, (ii) HRG‐induced ERK activity is much more robust to the ERK cascade inhibitor U0126 than EGF‐induced ERK activity, and (iii) phosphoinositol‐3 kinase is a major regulator of post‐peak but not pre‐peak EGF‐induced ERK activity. Sensitivity analysis leads to the hypothesis that ERK activation is robust to parameter perturbation at high ligand doses, while Akt activation is not.https://doi.org/10.1038/msb4100188breast cancerkinetic analysismathematical modelingreceptor tyrosine kinases
spellingShingle Marc R Birtwistle
Mariko Hatakeyama
Noriko Yumoto
Babatunde A Ogunnaike
Jan B Hoek
Boris N Kholodenko
Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
Molecular Systems Biology
breast cancer
kinetic analysis
mathematical modeling
receptor tyrosine kinases
title Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
title_full Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
title_fullStr Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
title_full_unstemmed Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
title_short Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
title_sort ligand dependent responses of the erbb signaling network experimental and modeling analyses
topic breast cancer
kinetic analysis
mathematical modeling
receptor tyrosine kinases
url https://doi.org/10.1038/msb4100188
work_keys_str_mv AT marcrbirtwistle liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses
AT marikohatakeyama liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses
AT norikoyumoto liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses
AT babatundeaogunnaike liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses
AT janbhoek liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses
AT borisnkholodenko liganddependentresponsesoftheerbbsignalingnetworkexperimentalandmodelinganalyses